---
title: "Median Technologies Reports 36.95 Million Shares and 36.88 Million Voting Rights"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/275636904.md"
datetime: "2026-02-11T16:45:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275636904.md)
  - [en](https://longbridge.com/en/news/275636904.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275636904.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/275636904.md) | [繁體中文](https://longbridge.com/zh-HK/news/275636904.md)


# Median Technologies Reports 36.95 Million Shares and 36.88 Million Voting Rights

Median Technologies SA has disclosed that, as of January 31, 2026, the company has a total of 36,948,314 issued shares. The number of real voting rights, excluding treasury shares, is 36,878,376, while the theoretical number of voting rights, including treasury shares, is 36,925,114. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260211372264) on February 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相关股票

- [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/zh-CN/quote/588130.CN.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/zh-CN/quote/512290.CN.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-CN/quote/510660.CN.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-CN/quote/512010.CN.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [Proshares UltraShort Nasdaq Biotech (BIS.US)](https://longbridge.com/zh-CN/quote/BIS.US.md)

## 相关资讯与研究

- [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/zh-CN/news/281174211.md)
- [RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 | RNXT Stock News](https://longbridge.com/zh-CN/news/281410663.md)
- [07:45 ETPLEOPHARMA, INC. to Present at the Centri Capital Conference in New York](https://longbridge.com/zh-CN/news/281012893.md)
- [Telomir seeks FDA approval for Telomir-1 to treat breast cancer](https://longbridge.com/zh-CN/news/281346305.md)
- [Io Biotech Inc - Files Voluntary Chapter 7 Bankruptcy Petition On March 31, 2026 - SEC Filing](https://longbridge.com/zh-CN/news/281187506.md)